Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
Growth retardation is well known in patients with severe forms of juvenile idiopathic
arthritis. Especially those who were under additional treatment with glucocorticoids for high
disease activity. The hypothesis is, that treatment with growth hormone can, at leat in part,
overcome growth hormone resistance state and increase final height. In a controlled study we
follow patients with juvenile idiopathic arthritis with and without growth hormone treatment
until final height. Additionally, we are interested in bone density development in those
treated with growth hormone.